Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression.
The Journal of international medical research（2023）
摘要
The findings are complex, but the overall data suggest that AKR1B10 is suitable as a tumor marker in patients with elevated levels at the time of diagnosis.
更多查看译文
关键词
Aldo-keto reductase family 1 member B10, breast cancer, cytotoxic chemotherapy, tumor marker, neoadjuvant therapy, surgery, treatment response, hormone receptor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要